Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia

Published:2019-05-17 Issue:2 Volume:6 Page:37-50
ISSN:2196-2979
Container-title:Current Behavioral Neuroscience Reports
language:en
Short-container-title:Curr Behav Neurosci Rep

Author:

Koola Maju Mathew,Praharaj Samir Kumar,Pillai Anilkumar

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Behavioral Neuroscience,Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1007/s40473-019-00174-5.pdf

Reference245 articles.

1. • Hoskins RG. Oxygen metabolism in schizophrenia. Arch Neurol Psychiatr. 1937;38(6):1261–70 This is presumably the first publication on oxygen metabolism in schizophrenia.

2. • Hoffer A, Osmond H, Smythies J. Schizophrenia; a new approach. II. Result of a year’s research. J Ment Sci. 1954;100(418):29–45 This is one of the first publications on oxidative stress in schizophrenia.

3. Mahadik SP, Scheffer RE. Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 1996;55(1–2):45–54.

4. Ramchand CN, Davies JI, Tresman RL, Griffiths IC, Peet M. Reduced susceptibility to oxidative damage of erythrocyte membranes from medicated schizophrenic patients. Prostaglandins Leukot Essent Fatty Acids. 1996;55(1–2):27–31.

5. Reddy RD, Yao JK. Free radical pathology in schizophrenia: a review. Prostaglandins Leukot Essent Fatty Acids. 1996;55(1–2):33–43.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative Pharmacology in the Treatment of Substance Use Disorders;Journal of Dual Diagnosis;2023-12-20

2. Age of Onset Moderates the Association between Total Antioxidant Capacity and Cognitive Deficits in Patients with Drug-Naïve Schizophrenia;Antioxidants;2023-06-12

3. Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia;CNS Drugs;2022-07-13

4. Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase;RSC Advances;2022

5. Galantamine as Adjunctive Treatment for Ameliorating Negative Symptoms of Schizophrenia Patients;Jundishapur Journal of Chronic Disease Care;2021-08-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3